Therapy Treatment for CRPS Within a Clinical Setting
NCT07930650, Completed, Walton Centre NHS Foundation Trust
Trial 8
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Therapy Treatment for CRPS Within a Clinical Setting | ClinicalTrials.gov |
| NCT number | NCT07930650 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Enrollment | 90 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Walton Centre NHS Foundation Trust | ClinicalTrials.gov |
| Conditions | Chronic Regional Pain Syndrome | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | The Patient-Specific Functional Scale | From baseline (initial CRPS therapy assessment) to completion of CRPS therapy treatment (up to 4 years) | This questionnaire can be used to quantify activity limitation and measure meaningful changes in activity. | ClinicalTrials.gov |
| Secondary | Patient function | From baseline (initial CRPS therapy assessment) to completion of CRPS therapy treatment (up to 4 years) | The 'interference with general activity' subscale of the BPI (excluding the walking sub-question in patients affected by CRPS of the upper limb) will be used to assess function | ClinicalTrials.gov |
| Secondary | Pre and post pain intensity | From baseline (initial CRPS therapy assessment) to completion of CRPS therapy treatment (up to 4 years) | Average and worst post-treatment pain intensity compared with before treatment. This is recorded in the BPI questionnaire on a 0-10 NRS where 0 = 'no pain' and 10 = 'pain as bad as you can imagine' | ClinicalTrials.gov |
| Secondary | Patient Neglect | From baseline (initial CRPS therapy assessment) to completion of CRPS therapy treatment (up to 4 years) | Measurement of neglect like symptoms will be taken using the Neglect like symptom questionnaire. This questionnaire is used to confirm the presence of neglect-like symptoms in CRPS patients | ClinicalTrials.gov |
| Secondary | Patient quality of life | From baseline (initial CRPS therapy assessment) to completion of CRPS therapy treatment (up to 4 years) | The EuroQOL-5D-5L measure will be used. Patient perceived global impression of change will be recorded via this questionnaire - this self-report measure reflects a patient's belief about the efficacy of treatment and is widely used in chronic pain clinical trials. Additionally case notes will be reviewed to obtain information regarding condition chronicity, age, gender, medications, details regarding CRPS therapy treatment, number of treatments sessions and discharge outcomes. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.3.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 4a570df2e7274cee2d4fa2959402fab41880e2cd412e4b590390035fbea69391 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
Release trials-2026-11-12-0.3.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.